Dr. Floyd Romesberg, one of the company’s co-founders, made news last year when he and a team of scientists successfully incorporated two synthetic nucleotide bases into the DNA sequence of a strain of E.coli bacteria. In a announcement yesterday, the company claimed to have taken its research a step further by incorporating and replicating brand new amino acids made with these synthetic bases into proteins.

Read More at www.motherboard.vice.com